These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 18359587)
1. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations. Pilcer G; Vanderbist F; Amighi K Int J Pharm; 2008 Jun; 358(1-2):75-81. PubMed ID: 18359587 [TBL] [Abstract][Full Text] [Related]
2. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations. Marriott C; MacRitchie HB; Zeng XM; Martin GP Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848 [TBL] [Abstract][Full Text] [Related]
3. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Zeng XM; MacRitchie HB; Marriott C; Martin GP Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction. Martin GP; MacRitchie HB; Marriott C; Zeng XM Pharm Res; 2006 Sep; 23(9):2210-9. PubMed ID: 16900410 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery. Pilcer G; Vanderbist F; Amighi K Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609 [TBL] [Abstract][Full Text] [Related]
6. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation. Pilcer G; Sebti T; Amighi K Pharm Res; 2006 May; 23(5):931-40. PubMed ID: 16715383 [TBL] [Abstract][Full Text] [Related]
7. Entrainment of lactose inhalation powders: a study using laser diffraction. Watling CP; Elliott JA; Cameron RE Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708 [TBL] [Abstract][Full Text] [Related]
8. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine. Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683 [TBL] [Abstract][Full Text] [Related]
9. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines. Wong W; Crapper J; Chan HK; Traini D; Young PM J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579 [TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery. Li X; Vogt FG; Hayes D; Mansour HM Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736 [TBL] [Abstract][Full Text] [Related]
11. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699 [TBL] [Abstract][Full Text] [Related]
12. In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates. Feddah MR; Brown KF; Gipps EM; Davies NM J Pharm Pharm Sci; 2000; 3(3):318-24. PubMed ID: 11177650 [TBL] [Abstract][Full Text] [Related]
13. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler. de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246 [TBL] [Abstract][Full Text] [Related]
14. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI). Hoe S; Traini D; Chan HK; Young PM Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086 [TBL] [Abstract][Full Text] [Related]
15. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors. Taki M; Marriott C; Zeng XM; Martin GP Int J Pharm; 2010 Mar; 388(1-2):40-51. PubMed ID: 20026261 [TBL] [Abstract][Full Text] [Related]
16. Comparison of laser diffraction measurements by Mastersizer X and Spraytec to characterize droplet size distribution of medical liquid aerosols. Lelong N; Junqua-Moullet A; Diot P; Vecellio L J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):94-102. PubMed ID: 23668547 [TBL] [Abstract][Full Text] [Related]
17. Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations. Zeng XM; MacRitchie HB; Marriott C; Martin GP Pharm Res; 2006 Sep; 23(9):2200-9. PubMed ID: 16900411 [TBL] [Abstract][Full Text] [Related]
18. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate. Thi TH; Danède F; Descamps M; Flament MP Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120 [TBL] [Abstract][Full Text] [Related]
19. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. Chiou H; Li L; Hu T; Chan HK; Chen JF; Yun J Int J Pharm; 2007 Feb; 331(1):93-8. PubMed ID: 17052870 [TBL] [Abstract][Full Text] [Related]
20. The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique. Taki M; Marriott C; Zeng XM; Martin GP Eur J Pharm Biopharm; 2011 Feb; 77(2):283-96. PubMed ID: 21185373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]